Enovis (ENOV) Depreciation & Amortization (CF) (2010 - 2026)
Enovis (ENOV) reported Depreciation & Amortization (CF) of $73.4 million for Q2 2026, up 2.69% year-over-year from $71.4 million in Q2 2025, and down 4.75% quarter-over-quarter from $77.0 million in Q4 2025.
Enovis (ENOV) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $73.4 million in Q2 2026.
- Depreciation & Amortization (CF) for Q2 2026 came in at $73.4 million, up 2.69% year-over-year; the trailing twelve-month figure through Apr 2026 was $296.3 million (up 4.76% YoY), and the FY2025 annual result was $294.4 million, up 3.36% from the prior year.
- Depreciation & Amortization (CF) declined to $73.4 million in Q2 2026 per ENOV's latest filing, from $77.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $97.4 million in Q2 2023 and troughed at $7.6 million in Q1 2023.
- A 5-year average of $64.1 million and a median of $71.2 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) plunged 88.48% in 2023, then surged 865.08% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $52.3 million in 2022, then climbed by 8.34% to $56.6 million in 2023, then soared by 31.42% to $74.4 million in 2024, then advanced by 3.51% to $77.0 million in 2025, then retreated by 4.75% to $73.4 million in 2026.
- Business Quant data shows ENOV's Depreciation & Amortization (CF) at $73.4 million in Q2 2026, $77.0 million in Q4 2025, and $74.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | 73.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 73.36 Mn |
| Apr 3, 2026 | 73.36 Mn |
| Dec 31, 2025 | 77.01 Mn |
| Dec 31, 2025 | 77.01 Mn |
| Oct 3, 2025 | 74.38 Mn |
| Oct 3, 2025 | 74.38 Mn |
| Jul 4, 2025 | 71.55 Mn |
| Jul 4, 2025 | 71.55 Mn |
| Apr 4, 2025 | 71.44 Mn |
| Apr 4, 2025 | 71.44 Mn |
| Dec 31, 2024 | 74.40 Mn |
| Dec 31, 2024 | 74.40 Mn |
| Sep 27, 2024 | 71.23 Mn |
| Sep 27, 2024 | 71.23 Mn |
| Jun 28, 2024 | 65.76 Mn |
| Jun 28, 2024 | 65.76 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Mar 29, 2024 | 73.40 Mn |
| Dec 31, 2023 | 56.62 Mn |
| Dec 31, 2023 | 56.62 Mn |